These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18830898)

  • 21. High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus.
    Huck S; Jamin C; Youinou P; Zouali M
    J Autoimmun; 1998 Oct; 11(5):449-55. PubMed ID: 9802928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow.
    Fuda FS; Karandikar NJ; Chen W
    Am J Clin Pathol; 2009 Nov; 132(5):733-7. PubMed ID: 19846815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.
    Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G
    Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From model cell line to in vivo gene expression: disease-related intestinal gene expression in IBD.
    Schulze HA; Häsler R; Mah N; Lu T; Nikolaus S; Costello CM; Schreiber S
    Genes Immun; 2008 Apr; 9(3):240-8. PubMed ID: 18340362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavonoids inhibit the genotoxicity of hydrogen peroxide (H(2)O(2)) and of the food mutagen 2-amino-3-methylimadazo[4,5-f]-quinoline (IQ) in lymphocytes from patients with inflammatory bowel disease (IBD).
    Najafzadeh M; Reynolds PD; Baumgartner A; Anderson D
    Mutagenesis; 2009 Sep; 24(5):405-11. PubMed ID: 19553277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
    Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
    Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
    Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population.
    Chen B; Zeng Z; Hou J; Chen M; Gao X; Hu P
    Scand J Gastroenterol; 2009; 44(6):720-6. PubMed ID: 19263269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic influence on the levels of circulating CD5 B lymphocytes.
    Kipps TJ; Vaughan JH
    J Immunol; 1987 Aug; 139(4):1060-4. PubMed ID: 3112220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
    J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher proportions of peripheral CD19+CD5+ B cells predict the effect of corticosteroid in patients with late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
    Fu HX; Xu LP; Liu DH; Liu KY; Chen H; Han W; Zhang XH; Wang Y; Wang FR; Wang JZ; Zhao T; Zhang YY; Chen Y; Huang XJ
    Chin Med J (Engl); 2011 May; 124(10):1517-23. PubMed ID: 21740809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single cell analysis of adenoid CD5+ B cells and their protective contributions to nasopharyngeal immunity.
    Arita M; Kodama S; Suzuki M; Mogi G
    Laryngoscope; 2003 Mar; 113(3):484-91. PubMed ID: 12616201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5-positive B cell subsets in secondary progressive multiple sclerosis.
    Niino M; Fukazawa T; Minami N; Amino I; Tashiro J; Fujiki N; Doi S; Kikuchi S
    Neurosci Lett; 2012 Aug; 523(1):56-61. PubMed ID: 22732449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.
    Jacobi AM; Reiter K; Mackay M; Aranow C; Hiepe F; Radbruch A; Hansen A; Burmester GR; Diamond B; Lipsky PE; Dörner T
    Arthritis Rheum; 2008 Jun; 58(6):1762-73. PubMed ID: 18512812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress-related peripheral neuroendocrine-immune interactions in women with ulcerative colitis.
    Langhorst J; Cobelens PM; Kavelaars A; Heijnen CJ; Benson S; Rifaie N; Dobos GJ; Schedlowski M; Elsenbruch S
    Psychoneuroendocrinology; 2007; 32(8-10):1086-96. PubMed ID: 17933470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The immune status changes in patients with inflammatory bowel disease under the influence of mesenchymal stromal cells and infliximab therapy].
    Lazebnik LB; Sagynbaeva VÉ; Knyazev OV; Parfenov AI; Efremov LI; Guseĭnzade MD; Ruchkina IN; Konopliannikov AG; Iakovleva MV; Astrelina TA
    Eksp Klin Gastroenterol; 2011; (9):11-7. PubMed ID: 22629769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.